GUEST EDITORJeff Hartzler
Training generally sits in a unique position within the business. On the commercial side, it may work with both sales and marketing, helping to optimize business execution. On the medical side, it may work across clinical operations, biodata statistics, clinical medical affairs and even some of the commercial teams (as with a launch). One of the benefits of sitting between these various functions is the ability to identify opportunities that can drive business outcomes.
I am sure you have experienced this mindset from your stakeholders: Training is often seen as something important, but never a priority. This is why some teams are so quick to cancel or reduce training time for their teams when critical business needs arise (such as the big fourth quarter push to hit the sales goal).
The challenge that we often face as learning leaders is freeing up resources (time, people, money) to take on new projects. Most training budgets are tight to begin with, and those resources may already be allocated to defined business needs.
In these situations, there is little or no room to reallocate, and the only other solution is to ask for more – more money, more headcount, etc. This is never an easy task, yet there are some creative ways to deliver that you could try:
While the above are not in any set order of attempt, there may be an opportunity to blend the approaches to secure the additional needed resources. Many times, it starts with the candid conversation of the true need, where it sits on the priority list and if your stakeholder finds true value in the task at hand.
Have you ever had a stakeholder come to you and say, “we need training” and you respond with “that’s great, what do we need to train on?” and they look at you like they have no idea what they asked you? This is the opportunity to have that deep partnership discussion on the specific need and what will be required to deliver something amazing in partnership with them and their team.
Jeff Hartzler is head of U.S. learning and development for UCB Pharma and a vice president of the LTEN Board of Directors. Email Jeff at jeff.hartzler@ucb.com.